Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$0.55 - $0.98 $5,222 - $9,306
-9,496 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$0.9 - $1.31 $8,546 - $12,439
9,496 New
9,496 $9,000
Q2 2021

Aug 12, 2021

SELL
$1.6 - $2.02 $65,134 - $82,232
-40,709 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$1.86 - $2.87 $36,496 - $56,315
19,622 Added 93.05%
40,709 $80,000
Q4 2020

Feb 02, 2021

BUY
$1.65 - $2.43 $32,021 - $47,159
19,407 Added 1155.18%
21,087 $43,000
Q3 2020

Oct 14, 2020

SELL
$1.6 - $2.35 $8,232 - $12,090
-5,145 Reduced 75.38%
1,680 $2,000
Q2 2020

Jul 13, 2020

BUY
$1.33 - $2.76 $1,512 - $3,138
1,137 Added 19.99%
6,825 $15,000
Q1 2020

Apr 29, 2020

SELL
$0.97 - $2.85 $161,501 - $474,513
-166,496 Reduced 96.7%
5,688 $8,000
Q4 2019

Feb 05, 2020

BUY
$1.69 - $3.8 $290,990 - $654,299
172,184 New
172,184 $654,000
Q3 2019

Oct 15, 2019

SELL
$0.61 - $2.21 $610 - $2,210
-1,000 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$0.51 - $0.86 $510 - $860
-1,000 Reduced 50.0%
1,000 $0
Q1 2019

Apr 18, 2019

SELL
$0.51 - $0.82 $561 - $902
-1,100 Reduced 35.48%
2,000 $0
Q4 2018

Jan 16, 2019

BUY
$0.48 - $1.1 $1,327 - $3,041
2,765 Added 825.37%
3,100 $1,000
Q3 2018

Oct 23, 2018

SELL
$1.06 - $1.69 $9,305 - $14,836
-8,779 Reduced 96.32%
335 $0
Q2 2018

Jul 30, 2018

BUY
$1.56 - $2.51 $13,216 - $21,264
8,472 Added 1319.63%
9,114 $14,000
Q1 2018

Apr 26, 2018

BUY
$0.91 - $2.24 $584 - $1,438
642 New
642 $1,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $230M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.